RenovoRx
RNXT
25 hedge funds and large institutions have $11.6M invested in RenovoRx in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
16% more capital invested
Capital invested by funds: $9.98M → $11.6M (+$1.6M)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4.32% less ownership
Funds ownership: 28.36% → 24.04% (-4.3%)
7% less funds holding
Funds holding: 27 → 25 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$362K |
| 2 |
Renaissance Technologies
New York
|
+$255K |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$85K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$36.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$24.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$682K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$524K |
| 3 |
AIC
AWM Investment Company
New York
|
-$472K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$275K |
| 5 |
CCM
Corsair Capital Management
New York
|
-$105K |
RNXT Hedge Fund Activity: Q2 2025 in Review
25 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q2 2025, worth a combined $11.6M — up 16% from $9.98M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of RNXT and 5 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $362K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $682K sold.
- 25 institutional investors held RenovoRx (RNXT) as of Q2 2025, down from 27 in Q1 2025.
- Funds reported $11.6M of RenovoRx stock for Q2 2025, up 16% quarter-over-quarter.
- 5 funds opened new RenovoRx positions in Q2 2025 and 7 closed out, a net change of -2 holders.
- The largest RenovoRx buyer in Q2 2025 was Vanguard Group, an estimated $362K added.
- The largest RenovoRx seller in Q2 2025 was Alyeska Investment Group, an estimated $682K sold.
Based on aggregated 13F filings for Q2 2025.